Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis clinical trials

Explore recruiting coronary atherosclerotic status in women with postmenopausal osteoporosis clinical trials.

Also recruiting in Europe

Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of Romosozumab vs. Denosumab on Coronary Atherosclerotic Damage in Postmenopausal Osteoporotic Women: A Phase IV, Low-Risk, Pharmacological Intervention Study. ATRIO Study.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis trials by city

Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Toronto Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Vancouver Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Montreal Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Calgary Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Edmonton Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Ottawa Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Winnipeg Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Quebec City Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Hamilton Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Kitchener Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in London Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Halifax Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in New York Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Los Angeles Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Chicago Coronary Atherosclerotic Status In Women With Postmenopausal Osteoporosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease